Just days ago, Bayer AG announced one of the largest drug-discovery alliances ever created. Bayer will pay Millennium Pharmaceuticals, Inc. $465 million. In return, over a six-year period, Millennium will use genomics techniques to identify cures for various diseases. Millennium must deliver 225 drug “targets” or proteins that may be useful in designing drugs. MORE […]
“September 28, 1998 Intelligence: Late Breaking Lab News”
- By Robert Michel
- > From the Volume V No. 13 - September 28, 1998 Issue
